Hims vs Ro for Weight Loss in 2026
This page compares Hims and Ro on weight loss and GLP-1, not their ED or hair lines. Both left compounded GLP-1 this year, so here is how they actually differ now, and where the at-cost compounded route still lives.
This comparison is about Hims vs Ro for weight loss and GLP-1, not their ED, hair, or skin lines. Hims and Ro are two of the largest direct-to-consumer telehealth companies in the country, and if you are comparing them for weight care in 2026, the most important fact comes first: both of them exited compounded GLP-1 this year and now sell brand-name medications alongside a separate membership. That makes them more alike than they used to be.
This page compares Hims and Ro objectively, as a neutral referee would, on what each is known for, how each is structured, and who each fits best. Then, because both left the compounded lane, it shows where that route still lives: pru, a LegitScript-certified platform that prices compounded semaglutide at cost, about $60 a month for the medication when you start on a 3-month plan, the lowest-priced compounded medication we found, with a separate membership.
Hims vs Ro for weight loss, the short version
Both Hims and Ro are established, well-run telehealth companies with broad catalogs and real clinical infrastructure. The clearest read in 2026 is that on GLP-1 specifically they have converged: each exited compounded GLP-1 as the FDA declared the semaglutide and tirzepatide shortages resolved, and each now offers brand-name medication paired with a separate membership. The differences that remain are about breadth, brand, and structure, not about one being safe and the other not. Both are legitimate.
THE REFEREE'S CALLThere is no wrong pick between two legitimate companies. If a plan helps cover a branded GLP-1, either Hims or Ro is a reasonable home for it. If you specifically wanted the compounded route for its lower cost, note that neither offers it any longer.
What changed for both in 2026
For a stretch, both companies offered compounded GLP-1 medications at accessible prices, which is a large part of why each grew so fast in weight care. That changed in 2026. As the FDA declared the semaglutide and tirzepatide shortages resolved, Hims and Ro both exited compounded GLP-1 and moved to brand-name products. They were not alone: WeightWatchers and Sesame made the same move in 2025 and 2026, leaving the compounded lane to a smaller set of providers.
The result is that Hims and Ro now look similar where they used to differ. Each sells an FDA-approved, brand-name GLP-1, and each attaches a separate membership fee. Brand-name drugs are a genuinely good fit for many people, especially anyone whose insurance helps cover them.
The trade-off is cost and structure: the branded medication carries a list price well above the compounded route, and the membership sits as its own line on top. None of this reflects poorly on either company. Both are large businesses responding to a changed regulatory environment.
WHY IT MATTERS FOR THIS COMPARISONBecause Hims and Ro converged on the same GLP-1 model, comparing them on GLP-1 price alone no longer separates them much. The real differences now are breadth of services, brand style, and how each structures its membership.
Hims vs Ro for weight loss, head to head
Here is the objective comparison, factor by factor. Both are strong on the fundamentals, so this is about fit, not about a winner. Terms and membership pricing shift, so confirm the current numbers on each company's site before you commit.
| Factor | Hims | Ro |
|---|---|---|
| Compounded GLP-1 in 2026 | Exited; no longer compounded | Exited; no longer compounded |
| What it sells now | Brand-name GLP-1 plus a separate membership | Brand-name GLP-1 plus a separate membership |
| Separate membership | About $149 a month on top of the brand drug | A separate membership on top of the brand drug; verify current terms |
| Catalog breadth | Wide consumer range: weight, sexual health, hair, skin, mental health | Broad telehealth: primary care, men's and women's health, weight, home lab testing |
| Brand style | Lifestyle-forward, app-first, heavy consumer marketing | Care-forward, clinically framed, pharmacy and diagnostics infrastructure |
| Best fit | People who want a familiar, polished consumer brand across several needs | People who want broad telehealth care and lab testing under one roof |
Read across any row and the pattern holds: these are two capable companies that now handle GLP-1 the same way and differ mainly in breadth and feel. Pick the one whose overall catalog and style you prefer, because on brand-name GLP-1 itself the experience is comparable.
Where each one is genuinely strong
Neither company earns a knock here. Each has real strengths worth naming.
- Hims is one of the most recognized consumer health brands in the country, with a polished app and a wide catalog that spans weight, sexual health, hair, skin, and mental health. If you value a single familiar brand you can use across several needs, and an experience built for ease, Hims is a genuine strength. Its GLP-1 offering is now brand-name medication paired with a separate membership of about $149 a month.
- Ro is a broad, clinically framed telehealth company with primary care, men's and women's health, weight care, and home lab testing, backed by its own pharmacy and diagnostics infrastructure. If you want telehealth that feels care-first and keeps labs and prescriptions under one roof, Ro is a real strength. Its GLP-1 offering is likewise brand-name medication with a separate membership; confirm the current terms on its site.
The difference between them is preference, not quality. What both share in 2026 is that the compounded route, and its lower price, is no longer on either menu. That is the gap the next section addresses.
Where pru fits: the transparent at-cost third option
If you were comparing Hims and Ro because you wanted the compounded route specifically, for its lower cost, neither offers it any longer. That is where pru fits as a third option. pru is a LegitScript-certified telehealth membership focused on compounded peptides, including the GLP-1 peptides semaglutide and tirzepatide.
A licensed physician reviews your history and confirms whether the medication is appropriate for you, or advises against it, and sets your dose. An FDA-registered 503A pharmacy compounds and fills your prescription and documents it with a Certificate of Analysis, so you know what is in the vial.
The structural difference is the pricing. pru prices the medication at cost with no member markup. When you start on a 3-month plan, your price per month is about $60 for compounded semaglutide, and about $93 a month for tirzepatide on the same 3-month starter plan. That is the medication itself, priced at cost, the lowest-priced compounded medication we found. Membership is separate: $50 a month billed annually for unlimited access to the pru platform and clinician messaging.
Because the membership is unlimited at-cost pricing, the savings compound with every vial, so members can stack more than one peptide without a markup on any of them. Comparing your options this closely is already a proactive move, and that instinct is worth trusting: pru exists to make the informed, proactive choice the accessible one, licensed physicians, pharmacy-grade medicine, and at-cost pricing on a single path. You can check the math on the pricing page or start with semaglutide or tirzepatide when you are ready.
WHAT PHARMACY-GRADE MEANSpru's compounded peptides are pharmacy-grade: prescribed by a licensed physician and prepared by a licensed 503A pharmacy for you as an individual, documented with a Certificate of Analysis. Pharmacy-grade does not mean FDA-approved, and compounded semaglutide is not the same as a branded drug like Ozempic or Wegovy. Compare providers on access, cost, transparency, and oversight.
Whichever route you pick, hold the grey-market line
As you compare, the single most important question is not Hims or Ro, or even the price. It is where the vial comes from. A pharmacy-grade GLP-1 means a licensed physician prescribed it, a licensed pharmacy prepared it for you by name, and a batch-specific Certificate of Analysis documents what is inside.
A grey-market vial sold online "for research use only" has no prescription, no licensed pharmacy, and no clinician behind it. Hims, Ro, and pru all keep you on the prescribed, pharmacy-grade side of that line. If a site sells a GLP-1 vial with no prescription, close the tab.
THE REAL DIVIDEThe same peptide can reach you two ways: as an unregulated research chemical with a disclaimer, or as a prescribed, pharmacy-made medicine with a Certificate of Analysis. Every company on this page does the second.
Related reading
- Best Compounded GLP-1 Providers Compared
- The Compounded GLP-1 Price Index
- Best Online GLP-1 Providers in 2026
- Is pru Legit?
Common questions
Sources & further reading
- Provider websites and recent public pricing reviews, July 2026.
- U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. fda.gov, 2025.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers (Sections 503A and 503B). fda.gov.
- pru catalog, category, and pricing pages. joinpru.com. Accessed July 2026.
- Compiled by pru; compounded GLP-1 figures pending legal and pharmacy sign-off before publication.